Finnian Kenny was part of a Kymriah trial at Melbourne’s Peter MacCallum Cancer Centre Source: Supplied
A treatment for two aggressive blood cancers has been approved for use in Australia, but patients could be slugged with huge bills for care until governments agree on who covers the cost. The therapy involves genetically modifying a patient's immune cells, so they recognise and kill their cancer.
A treatment for two aggressive blood cancers has been approved for use in Australia, but patients could be slugged with huge bills for care until governments agree on who covers the cost. The therapy involves genetically modifying a patient's immune cells, so they recognise and kill their cancer.
